NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington (DC): National Academies Press (US); 2010.

Cover of The Value of Genetic and Genomic Technologies

The Value of Genetic and Genomic Technologies: Workshop Summary.

Show details

Roundtable on Translating Genomic-Based Research for Health*

WYLIE BURKE (Chair), Professor and Chair, Department of Bioethics and Humanities, University of Washington, Seattle

BRUCE BLUMBERG, Co-Chief of Medical Genetics, Kaiser Permanente, and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group, Oakland, CA

DENISE E. BONDS, Medical Officer, Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD

C. THOMAS CASKEY, Director and Chief Executive Officer, The George & Cynthia Mitchell Distinguished Chair in Neurosciences, Executive Vice President of Molecular Medicine and Genetics, University of Texas Health Science Center at Houston

STEPHEN ECK, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company, Indianapolis, IN

ANDREW N. FREEDMAN, Branch Chief, Clinical and Translational Epidemiology Branch, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD

GEOFFREY GINSBURG, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University, Durham, NC

R. RODNEY HOWELL, Special Assistant to the Director, National Institute of Child Health and Human Development, Bethesda, MD

SHARON KARDIA, Professor and Chair of Epidemiology; Director, Public Health Genetics Program; Director, Life Science and Society Program; Co-Director, Center for Genomics & Public Health, University of Michigan School of Public Health, Ann Arbor

MOHAMED KHAN, American Medical Association; Associate Director of Translational Research, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY

MUIN KHOURY, Director, National Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA

ALLAN KORN, Chief Medical Officer, Senior Vice President, Clinical Affairs, Blue Cross and Blue Shield Association, Chicago, IL

DEBRA LEONARD, College of American Pathologists; Professor and Vice Chair for Laboratory Medicine, Director of the Clinical Laboratories, Weill Cornell Medical Center of Cornell University, New York, NY

MICHELE LLOYD-PURYEAR, Chief, Genetic Services Branch, Health Resources and Services Administration, Rockville, MD

ELIZABETH MANSFIELD, Director of Personalized Medicine, Food and Drug Administration, Silver Spring, MD

GARRY NEIL, Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson, New Brunswick, NJ

ROBERT L. NUSSBAUM, Chief, Division of Medical Genetics, Department of Medicine and Institute of Human Genetics, University of California–San Francisco School of Medicine

KIMBERLY POPOVITS, President and Chief Executive Officer, Genomic Health, Inc., Redwood City, CA

AIDAN POWER, Vice President and Global Head of Molecular Medicine, Pfizer Inc., New London, CT

RONALD PRZYGODZKI, Associate Director for Genomic Medicine, Biomedical Laboratory Research and Development, Department of Veterans Affairs, Washington, DC

AMELIE G. RAMIREZ, Dielmann Chair, Health Disparities and Community Outreach Research; Director, Institute for Health Promotion Research, University of Texas Health Science Center at San Antonio

LAURA LYMAN RODRIGUEZ, Senior Advisor to the Director for Research Policy, National Human Genome Research Institute, Bethesda, MD

ALLEN D. ROSES, Jefferson-Pilot Professor of Neurobiology and Genetics, Professor of Medicine (Neurology); Director, Deane Drug Discovery Institute; Senior Scholar, Fuqua School of Business, R. David Thomas Executive Training Center, Duke University, Durham, NC

KEVIN A. SCHULMAN, Professor of Medicine and Business Administration; Director, Center for Clinical and Genetic Economics; Associate Director, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC

SHARON TERRY, President and Chief Executive Officer, Genetic Alliance, Washington, DC

STEVEN TEUTSCH, Chair, Secretary’s Advisory Committee on Genetics, Health and Society; Chief Science Officer, Los Angeles County Department of Public Health, Los Angeles, CA

MARTHA TURNER, Assistant Director, American Nurses Association Center for Ethics and Human Rights, Silver Spring, MD

MICHAEL S. WATSON, Executive Director, American College of Medical Genetics, Bethesda, MD

CATHERINE A. WICKLUND, Past President, National Society of Genetic Counselors; Director, Graduate Program in Genetic Counseling; Assistant Professor, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL

IOM Staff

ADAM C. BERGER, Project Director

ERIN HAMMERS, Research Associate

ALEX REPACE, Senior Project Assistant

ANDREW POPE, Director, Board on Health Sciences Policy



Institute of Medicine Forums and Roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Copyright © 2010, National Academy of Sciences.
Bookshelf ID: NBK52762
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (529K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...